Lung Cancer Research Foundation
@lcrf.org
Mission: improve #LungCancer outcomes by funding research for the prevention, diagnosis, treatment and cure of lung cancer | #MedSky #OncSky
LCRF is pleased to announce five additional award recipients for its 2025 #LungCancer research grant program. Read more: LCRF.org/gr16a
January 6, 2026 at 3:30 PM
LCRF is pleased to announce five additional award recipients for its 2025 #LungCancer research grant program. Read more: LCRF.org/gr16a
Reposted by Lung Cancer Research Foundation
“Lung cancer tried to take my life three times. Research saved me—three times.”
Judith’s story isn’t just powerful—it’s possible because of donors like you. Right now, someone else is waiting for their breakthrough.
Give before midnight to DOUBLE your impact! LCRF.org/thirdchance
Judith’s story isn’t just powerful—it’s possible because of donors like you. Right now, someone else is waiting for their breakthrough.
Give before midnight to DOUBLE your impact! LCRF.org/thirdchance
December 31, 2025 at 10:30 PM
“Lung cancer tried to take my life three times. Research saved me—three times.”
Judith’s story isn’t just powerful—it’s possible because of donors like you. Right now, someone else is waiting for their breakthrough.
Give before midnight to DOUBLE your impact! LCRF.org/thirdchance
Judith’s story isn’t just powerful—it’s possible because of donors like you. Right now, someone else is waiting for their breakthrough.
Give before midnight to DOUBLE your impact! LCRF.org/thirdchance
Today’s the last day to make a tax-deductible gift in 2025—and the last chance to have your donation DOUBLED.
Judith survived #LungCancer three times, thanks to research made possible by donors like you.
Give now and make 2x the impact: LCRF.org/thirdchance
Judith survived #LungCancer three times, thanks to research made possible by donors like you.
Give now and make 2x the impact: LCRF.org/thirdchance
December 31, 2025 at 4:02 PM
Today’s the last day to make a tax-deductible gift in 2025—and the last chance to have your donation DOUBLED.
Judith survived #LungCancer three times, thanks to research made possible by donors like you.
Give now and make 2x the impact: LCRF.org/thirdchance
Judith survived #LungCancer three times, thanks to research made possible by donors like you.
Give now and make 2x the impact: LCRF.org/thirdchance
#LungCancer is still surrounded by silence and stigma—but Judith, a 3x survivor, fights to make lung cancer impossible to ignore.
Your support funds the research that saves lives. Donate by Dec 31 to DOUBLE your gift.
End the stigma. End lung cancer. LCRF.org/thirdchance
Your support funds the research that saves lives. Donate by Dec 31 to DOUBLE your gift.
End the stigma. End lung cancer. LCRF.org/thirdchance
December 29, 2025 at 4:45 PM
#LungCancer is still surrounded by silence and stigma—but Judith, a 3x survivor, fights to make lung cancer impossible to ignore.
Your support funds the research that saves lives. Donate by Dec 31 to DOUBLE your gift.
End the stigma. End lung cancer. LCRF.org/thirdchance
Your support funds the research that saves lives. Donate by Dec 31 to DOUBLE your gift.
End the stigma. End lung cancer. LCRF.org/thirdchance
“None of us are alone in this.”
When Shane’s mom was diagnosed with #LungCancer, he found hope through community—and through research that gave her more time.
Your support fuels that same hope.
Donate by Dec 31 to double your gift and help fund the next breakthrough. LCRF.org/thirdchance
When Shane’s mom was diagnosed with #LungCancer, he found hope through community—and through research that gave her more time.
Your support fuels that same hope.
Donate by Dec 31 to double your gift and help fund the next breakthrough. LCRF.org/thirdchance
December 23, 2025 at 4:30 PM
“None of us are alone in this.”
When Shane’s mom was diagnosed with #LungCancer, he found hope through community—and through research that gave her more time.
Your support fuels that same hope.
Donate by Dec 31 to double your gift and help fund the next breakthrough. LCRF.org/thirdchance
When Shane’s mom was diagnosed with #LungCancer, he found hope through community—and through research that gave her more time.
Your support fuels that same hope.
Donate by Dec 31 to double your gift and help fund the next breakthrough. LCRF.org/thirdchance
Yesterday, the FDA approved subcutaneous amivantamab for adult patients with EGFR-mutated non-small cell lung cancer (NSCLC.) This approval means shorter treatment times and fewer side effects. #lungcancer #QOL #lcsm
www.fda.gov/drugs/resour...
www.fda.gov/drugs/resour...
December 18, 2025 at 8:00 PM
Yesterday, the FDA approved subcutaneous amivantamab for adult patients with EGFR-mutated non-small cell lung cancer (NSCLC.) This approval means shorter treatment times and fewer side effects. #lungcancer #QOL #lcsm
www.fda.gov/drugs/resour...
www.fda.gov/drugs/resour...
“What gave me more time? Research.”
Judith survived 3 #LungCancer diagnoses over two decades. Stories like hers used to be rare—but thanks to research funded by donors like you, patients have more treatment options than ever.
Give by Dec 31 – your donation will be DOUBLED. LCRF.org/thirdchance
Judith survived 3 #LungCancer diagnoses over two decades. Stories like hers used to be rare—but thanks to research funded by donors like you, patients have more treatment options than ever.
Give by Dec 31 – your donation will be DOUBLED. LCRF.org/thirdchance
December 18, 2025 at 6:04 PM
“What gave me more time? Research.”
Judith survived 3 #LungCancer diagnoses over two decades. Stories like hers used to be rare—but thanks to research funded by donors like you, patients have more treatment options than ever.
Give by Dec 31 – your donation will be DOUBLED. LCRF.org/thirdchance
Judith survived 3 #LungCancer diagnoses over two decades. Stories like hers used to be rare—but thanks to research funded by donors like you, patients have more treatment options than ever.
Give by Dec 31 – your donation will be DOUBLED. LCRF.org/thirdchance
UT Health San Antonio and Mays Cancer Center are hosting the Advancing Cancer Research for Latinos and All Populations conference, Feb 18-20, 2026. Gain perspective on cancer health issues. Early bird registration through 12/18! #CancerResearchForAll #ACRLP LatinoCancer.org
Advancing Cancer Research for Latinos and All Populations | Long School of Medicine
Quicklinks
LatinoCancer.org
December 15, 2025 at 5:45 PM
UT Health San Antonio and Mays Cancer Center are hosting the Advancing Cancer Research for Latinos and All Populations conference, Feb 18-20, 2026. Gain perspective on cancer health issues. Early bird registration through 12/18! #CancerResearchForAll #ACRLP LatinoCancer.org
THREE #LungCancer diagnoses—and Judith is still here.
“Chemo, surgery, radiation, clinical trials… and hope. I’m alive today because of life-saving research—and people like YOU who make it possible.”
Give by Dec 31 and your donation will be matched! LCRF.org/thirdchance
“Chemo, surgery, radiation, clinical trials… and hope. I’m alive today because of life-saving research—and people like YOU who make it possible.”
Give by Dec 31 and your donation will be matched! LCRF.org/thirdchance
December 11, 2025 at 6:04 PM
THREE #LungCancer diagnoses—and Judith is still here.
“Chemo, surgery, radiation, clinical trials… and hope. I’m alive today because of life-saving research—and people like YOU who make it possible.”
Give by Dec 31 and your donation will be matched! LCRF.org/thirdchance
“Chemo, surgery, radiation, clinical trials… and hope. I’m alive today because of life-saving research—and people like YOU who make it possible.”
Give by Dec 31 and your donation will be matched! LCRF.org/thirdchance
This is the perfect time of year to set a goal to participate in some of New York's iconic endurance events! Team LCRF is looking for runners and cyclists to go the distance for lung cancer research in the United Airlines NYC Half on March 15 and the TD Five Boro Bike tour on May 3!
TeamLCRF.org 🏅
TeamLCRF.org 🏅
December 10, 2025 at 3:09 PM
This is the perfect time of year to set a goal to participate in some of New York's iconic endurance events! Team LCRF is looking for runners and cyclists to go the distance for lung cancer research in the United Airlines NYC Half on March 15 and the TD Five Boro Bike tour on May 3!
TeamLCRF.org 🏅
TeamLCRF.org 🏅
This morning, Will Reeve shared the stories and statistics behind the increase in lung cancer among women and non-smokers, and how new treatments are helping people live longer, with research bringing new hope. #AnyoneWithLungs #LungCancer #ResearchIsHope LCRF.org/gmc129
December 9, 2025 at 6:00 PM
This morning, Will Reeve shared the stories and statistics behind the increase in lung cancer among women and non-smokers, and how new treatments are helping people live longer, with research bringing new hope. #AnyoneWithLungs #LungCancer #ResearchIsHope LCRF.org/gmc129
Announcing the 2025 LCRF | Boehringer Ingelheim Early Career Investigator Awards: three awardees each received a $250k grant for projects focused on HER2-driven lung cancer. Read more about these scientists and the focus of their studies. LCRF.org/251209bi
December 9, 2025 at 3:15 PM
Announcing the 2025 LCRF | Boehringer Ingelheim Early Career Investigator Awards: three awardees each received a $250k grant for projects focused on HER2-driven lung cancer. Read more about these scientists and the focus of their studies. LCRF.org/251209bi
You did something incredible yesterday. Thanks to your generosity this #GivingTuesday, we’re one step closer to breakthroughs in #LungCancer detection, treatment, and prevention. Your gift is already at work, fueling research & giving hope to thousands of families. From all of us at LCRF: thank you.
December 3, 2025 at 4:03 PM
You did something incredible yesterday. Thanks to your generosity this #GivingTuesday, we’re one step closer to breakthroughs in #LungCancer detection, treatment, and prevention. Your gift is already at work, fueling research & giving hope to thousands of families. From all of us at LCRF: thank you.
Today is #GivingTuesday — and your gift has never mattered more. This year, we received a record number of proposals — actionable, innovative research that could transform the future of #LungCancer.
Until midnight tonight – your gift is doubled, thanks to a generous donor!
LCRF.org/givingtuesday
Until midnight tonight – your gift is doubled, thanks to a generous donor!
LCRF.org/givingtuesday
Donate to Giving Tuesday 2025
Support our cause by donating to Giving Tuesday 2025.
LCRF.org
December 2, 2025 at 11:01 PM
Today is #GivingTuesday — and your gift has never mattered more. This year, we received a record number of proposals — actionable, innovative research that could transform the future of #LungCancer.
Until midnight tonight – your gift is doubled, thanks to a generous donor!
LCRF.org/givingtuesday
Until midnight tonight – your gift is doubled, thanks to a generous donor!
LCRF.org/givingtuesday
Tomorrow, Dec. 3 @ 4pm ET — Together Separately livestream on #LungCancer breakthroughs of 2025. @balazshalmos.bsky.social & Dr. Lyudmila Bazhenova will join Dr. Isabel Preeshagul to look back upon all of the exciting research in 2025 and discuss what's to come: LCRF.org/together
Breakthroughs of 2025: a year-end review - Lung Cancer Research Foundation
This livestream is an opportunity to connect face-to-face with others who care about lung cancer. Our guest experts will look back upon all of the exciting research breakthrough in 2025 […]
LCRF.org
December 2, 2025 at 9:30 PM
Tomorrow, Dec. 3 @ 4pm ET — Together Separately livestream on #LungCancer breakthroughs of 2025. @balazshalmos.bsky.social & Dr. Lyudmila Bazhenova will join Dr. Isabel Preeshagul to look back upon all of the exciting research in 2025 and discuss what's to come: LCRF.org/together
#ScienceMadeSimple: FDA has granted accelerated approval to sevabertinib for treating HER2+ (ERBB2) #LungCancer. LCRF's Chief Scientific Officer, Dr. Toni Wozniak, explains what this means for patients. LCRF.org/sms25121
Sevabertinib for HER2+ lung cancer - Lung Cancer Research Foundation
The good news The U.S. Food and Drug Administration (FDA) has granted accelerated approval to sevabertinib for the treatment of adult patients with unresectable or metastatic non-squamous non-small…
LCRF.org
December 2, 2025 at 5:30 PM
#ScienceMadeSimple: FDA has granted accelerated approval to sevabertinib for treating HER2+ (ERBB2) #LungCancer. LCRF's Chief Scientific Officer, Dr. Toni Wozniak, explains what this means for patients. LCRF.org/sms25121
LCRF is pleased to announce this year's 2025 Scientific Grant Program awards. Eleven awardees received a total $1.65 million in funding for new #LungCancer research. Read more about these scientists and the focus of their studies. LCRF.org/2025awards
December 2, 2025 at 3:15 PM
LCRF is pleased to announce this year's 2025 Scientific Grant Program awards. Eleven awardees received a total $1.65 million in funding for new #LungCancer research. Read more about these scientists and the focus of their studies. LCRF.org/2025awards
Today is #GivingTuesday, and your donation to fund critical #LungCancer research will be DOUBLED thanks to a generous donor! Please give and fuel more breakthroughs that give hope to patients and families. LCRF.org/givingtuesday
Donate to Giving Tuesday 2025
Support our cause by donating to Giving Tuesday 2025.
LCRF.org
December 2, 2025 at 3:03 PM
Today is #GivingTuesday, and your donation to fund critical #LungCancer research will be DOUBLED thanks to a generous donor! Please give and fuel more breakthroughs that give hope to patients and families. LCRF.org/givingtuesday
We’ve never seen this much promise in #LungCancer research — but we can’t fund it all without you. LCRF.org/givingtuesday
"LCRF funding was instrumental in allowing me to complete and publish my project… now it’s the foundation of a clinical trial.” — Dr. Victoria Wang, Two-time LCRF Grantee
"LCRF funding was instrumental in allowing me to complete and publish my project… now it’s the foundation of a clinical trial.” — Dr. Victoria Wang, Two-time LCRF Grantee
Donate to Giving Tuesday 2025
Support our cause by donating to Giving Tuesday 2025.
LCRF.org
December 1, 2025 at 4:30 PM
We’ve never seen this much promise in #LungCancer research — but we can’t fund it all without you. LCRF.org/givingtuesday
"LCRF funding was instrumental in allowing me to complete and publish my project… now it’s the foundation of a clinical trial.” — Dr. Victoria Wang, Two-time LCRF Grantee
"LCRF funding was instrumental in allowing me to complete and publish my project… now it’s the foundation of a clinical trial.” — Dr. Victoria Wang, Two-time LCRF Grantee
Lung Cancer Awareness Month is coming to a close, but the reality is that #LungCancer deserves attention every day of the year. Keep the momentum going, and let's head into the coming year full of hope and determined to make a difference for everyone affected by this disease. #LCAM LCRF.org/LCAM
November 30, 2025 at 4:15 PM
Lung Cancer Awareness Month is coming to a close, but the reality is that #LungCancer deserves attention every day of the year. Keep the momentum going, and let's head into the coming year full of hope and determined to make a difference for everyone affected by this disease. #LCAM LCRF.org/LCAM
#FridayFacts: #LungCancer survivorship rates are increasing faster than ever, thanks to early detection and advances in research. Spread the word! Find graphics and information you can share at LCRF.org/LCAM. #LCAM
November 29, 2025 at 3:30 PM
#FridayFacts: #LungCancer survivorship rates are increasing faster than ever, thanks to early detection and advances in research. Spread the word! Find graphics and information you can share at LCRF.org/LCAM. #LCAM
On #Thanksgiving day, "family" is a word with great meaning. And when you care about people with #LungCancer, you become part of our second family. We hope that you are enjoying time with people you love. We are grateful for you and all you do! #HappyThanksgiving
November 27, 2025 at 2:15 PM
On #Thanksgiving day, "family" is a word with great meaning. And when you care about people with #LungCancer, you become part of our second family. We hope that you are enjoying time with people you love. We are grateful for you and all you do! #HappyThanksgiving
More women are lost to #LungCancer than to breast, cervical, and ovarian cancer combined. If you have lungs, you can get lung cancer. Learn more about how this disease affects women: LCRF.org/women #LCAM #WomenLC
November 26, 2025 at 4:04 PM
More women are lost to #LungCancer than to breast, cervical, and ovarian cancer combined. If you have lungs, you can get lung cancer. Learn more about how this disease affects women: LCRF.org/women #LCAM #WomenLC
Proud to represent LCRF at US Rep. Josh Gottheimer's event announcing several bills to benefit the #LungCancer community, with Dusty Donaldson, Valerie Brown, Dr. Upal Basu Roy, and LCRF board member Benay Taub, for whom the Benay Taub Lung Cancer Research Act is named. LCRF.org/taubact
November 25, 2025 at 10:00 PM
Proud to represent LCRF at US Rep. Josh Gottheimer's event announcing several bills to benefit the #LungCancer community, with Dusty Donaldson, Valerie Brown, Dr. Upal Basu Roy, and LCRF board member Benay Taub, for whom the Benay Taub Lung Cancer Research Act is named. LCRF.org/taubact